[Immunology and tumors. Effector cells]
- PMID: 6971636
[Immunology and tumors. Effector cells]
Abstract
Since Burnet expounded the theory of immune surveillance, various cells have been indicated as the "effectors" of the body immunological defence against tumours. Until recently, the ability to lyse tumour target cells was assigned to macrophages and the so-called thymus-dependent lymphocytes, known as killer T cells. The discovery of natural killer cells in mice recently has widened the number of effectors and the field of research in this sector. An examination is made of the features and main properties of these cell groups, and some questions are posed concerning their ability to cooperate in anti-neoplastic immunological defence.
Similar articles
-
[Cytolytic activity of macrophages and T-lymphocytes in regard to tumor cells in the presence of normal tissue cells].Eksp Onkol. 1990;12(4):77-8. Eksp Onkol. 1990. PMID: 2379495 Russian. No abstract available.
-
Host factors important in immune surveillance against tumours.IARC Sci Publ. 1982;(39):223-39. IARC Sci Publ. 1982. PMID: 6185418
-
An introduction to tumour immunology.Arch Immunol Ther Exp (Warsz). 1983;31(6):795-808. Arch Immunol Ther Exp (Warsz). 1983. PMID: 6611141
-
[Effect of chemotherapy on anticancer immune effector cells].Gan To Kagaku Ryoho. 1983 Mar;10(3):699-707. Gan To Kagaku Ryoho. 1983. PMID: 6410999 Review. Japanese.
-
[New insights into cytotoxic effector cells].Bull Cancer. 2005 Nov;92(11):935-43. Bull Cancer. 2005. PMID: 16316827 Review. French.